Published in Immunotherapy Weekly, January 23rd, 2000
There is currently no vaccine for hepatitis C virus (HCV) and the only available treatment, interferon alpha alone or in combination with ribavirin, has proven efficacious in less than 50% of patients.
"Given that approximately 200 million chronic HCV infections have been estimated worldwide, there is a pressing need to develop vaccination strategies aimed at preventing and possibly eradicating HCV infection," S. Abrignani and colleagues from the Chiron Research Center wrote ("Perspectives for a Vaccine Against...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.